术后瘢痕美容中Fespixon的验证:基于定量数码摄影分析
这项前瞻性安慰剂对照试验纳入46例术后横行瘢痕患者,左侧瘢痕用Fespixon、右侧用安慰剂,结合改良温哥华瘢痕量表、视觉模拟量表与数码摄影定量分析评估。Fespixon侧在色素沉着、血管分布、柔韧性、高度、瘙痒及患者满意度上均优于对照侧,多数色度与纹理特征也显著改善至Fespixon侧。
要点
- Fespixon侧主观评分在色素沉着、血管分布、柔韧性、高度、瘙痒及满意度上均优于对照侧。
- 数码摄影定量分析显示Fespixon侧多数色度与纹理特征显著改善。
- 作者认为该数码摄影定量分析系统是量化瘢痕外观的理想工具。
核心结论
- 研究验证了Fespixon对术后瘢痕愈合的疗效,依据不仅来自主观评估,也来自客观定量分析。
- 结果表明该数码摄影定量分析系统是量化瘢痕外观的理想工具。
研究设计与样本
- 前瞻性、安慰剂对照试验,纳入术后横行瘢痕患者46例,平均年龄52岁。
- 每例患者瘢痕左侧外用Fespixon、右侧外用安慰剂乳膏。
- 评估包括改良温哥华瘢痕量表、视觉模拟量表及每月数码摄影分析,色度信息用CIELAB与色调,纹理信息用对比度、相关性、同质性与熵。
主要发现
- 主观评估所有参数均显示Fespixon侧结果更优,色素沉着P=.043、血管分布P=.013、柔韧性P=.026、高度P=.002、瘙痒P=.039、患者满意度P=.012。
- 颜色与纹理趋势显示相对差异比增大,多数特征值显著偏向Fespixon侧:CIELAB-L* P=.000、色调R/G/B值P=.034/.001/.011、对比度P=.000、同质性P=.000、相关性P=.011、熵P=.000。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Unsightly scarring after surgery remains a dilemma. One of the challenges is the lack of objective scar assessment tools. OBJECTIVES: This study aimed to evaluate the efficacy of a novel medicine, Fespixon, for prevention and/or alleviation of post-skin incision scarring. A second aim was to demonstrate the practicality of our digital image analysis system to see if this could serve as a sensitive tool to assess scar improvement. METHODS: A prospective, placebo-controlled trial involving patients with postoperative transverse scars was conducted. Each patient received a topical formulation of Fespixon on the left part of the scar and placebo cream on the right. In addition to recording the subjective modified Vancouver Scar Scale and visual analog scale scores, we utilized digital photography for monthly scar analysis, with CIELAB and hue serving as the colorimetric information, and with contrast, correlation, homogeneity, and entropy providing texture information. RESULTS: Forty-six participants (mean age, 52 years) were enrolled in the trial. All the parameters of subjective assessment showed superior results for the Fespixon-treated side, with significant differences in pigmentation, vascularity, pliability, height, itchiness, and patient satisfaction (P = .043, .013, .026, .002, .039, .012, respectively). The trends in color and texture showed increased relative difference ratios, with significant differences in most of the eigenvalues towards the Fespixon-treated side, including CIELAB-L* (P = .000), hue-R,G,B (red, blue, green) values (P = .034, .001, .011), contrast (P = .000), homogeneity (P = .000), correlation (P = .011), and entropy (P = .000). CONCLUSIONS: We validated the efficacy of Fespixon for postoperative scar healing based not only on subjective assessments but also on objective quantitative analyses. The results also indicated that our digital photography quantitative analysis system is an ideal tool for quantification of scar appearance.
引用
- Huang TR, Chen SG, Chen JC, et al. Validation of Fespixon in Postoperative Scar Cosmesis Using Quantitative Digital Photography Analysis. Aesthet Surg J. 2023. PMID: 36624624. doi:10.1093/asj/sjad005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。